RBM

Gattaca Genomics Appoints Dr. Tyl Taylor as New Director of Genetics Services

Retrieved on: 
Thursday, March 7, 2024
Aneuploidy, RBM, Human Reproduction (journal), Reproductive medicine, Genetics, REACH, IVF, Associate, Society, Abstract, Genetic testing, Knowledge, Genomics, Management

Florida, March 06, 2024 (GLOBE NEWSWIRE) -- Gattaca Genomics, a leading name in genetic services, appoints Dr. Tyl Taylor as its new Director of Genetics Services.

Key Points: 
  • Florida, March 06, 2024 (GLOBE NEWSWIRE) -- Gattaca Genomics, a leading name in genetic services, appoints Dr. Tyl Taylor as its new Director of Genetics Services.
  • Dr. Taylor brings a wealth of experience and expertise in the field, making him a valuable addition to the Gattaca team.
  • In his role as the Director of Genetics Services at Gattaca, Dr. Taylor is poised to lead the team towards new heights in genetic research and reproductive technologies.
  • We are confident that under his guidance, Gattaca will continue to drive advancements in genetic services," said Michael Carbonara, CEO of Gattaca Genetics.

Juniper Research Announces Winners of Telco Innovation 2024 Awards

Retrieved on: 
Wednesday, January 24, 2024
5G, Telecommunications, Software, Networks, Internet, Technology, IOT (Internet of Things), Mobile, Wireless, Senior, Gold, Trust, Tata Communications, CRMS, CIS, Partnership, VodafoneZiggo, Tata, CX, RCS, Digital, Fraud, SMS, Investment, SLA, TransUnion, Conversational commerce, Gold Award, RBM, Research, News, EVP

“We are delighted to be recognised as the Best Conversational Commerce Solution Provider at the Juniper Research Future Digital Awards 2024.

Key Points: 
  • “We are delighted to be recognised as the Best Conversational Commerce Solution Provider at the Juniper Research Future Digital Awards 2024.
  • “We’re honoured to be recognised by Juniper Research in the Best Customer Data Platform category for our work alongside VodafoneZiggo,” said Nicky Peterse, Lead Principal Customer Success Manager at BlueConic.
  • “We’re delighted to be recognised for three years running by Juniper Research for our solution in the security and fraud space.
  • These awards affirm our continuous commitment to maintaining leadership in innovation for monetisation and anti-fraud services, benefitting mobile operators and enterprises globally.

Juniper Research: Apple’s RCS Support to Grow RCS Business Messaging Revenue by 500% Globally in Two Years

Retrieved on: 
Monday, January 8, 2024
Mobile, Wireless, Technology, Telecommunications, SMS, Ecosystem, OTT, Multimedia, IOS, Outlook, Research, RCS, Rich Communication Services, Fraud, Growth, RBM, Mobile phone

The report predicted this will increase the value proposition of RBM (RCS Business Messaging) amongst enterprises.

Key Points: 
  • The report predicted this will increase the value proposition of RBM (RCS Business Messaging) amongst enterprises.
  • Additionally, the research anticipated RCS will become a key technology for operators in the business messaging ecosystem, given the high levels of fraud affecting the SMS business messaging sector.
  • It predicted that the launch of RCS will enable operators to retain business messaging traffic over telecoms networks, as SMS adoption slows, and OTT business messaging channels continue to experience significant growth.
  • Apple’s introduction raises the profile of RCS, a technology that has historically been hindered by a lack of support, and can become a substitute for SMS business messaging traffic.”

Interop Technologies Implements Basic RCS Across Global Messaging Network

Retrieved on: 
Wednesday, November 15, 2023
Apps, Applications, Technology, Mobile, Wireless, Other Communications, Other Technology, Telecommunications, Communications, Software, Networks, RBM, EVP, MEF, RCS, SMS, Rich Communication Services, Interop, Mobile phone, Sales

Interop Technologies, a global leader in advanced mobile messaging technology, today announced the availability of a Basic RCS (Rich Communication Services) solution across their global messaging network.

Key Points: 
  • Interop Technologies, a global leader in advanced mobile messaging technology, today announced the availability of a Basic RCS (Rich Communication Services) solution across their global messaging network.
  • This solution provides mobile operators with an introduction to RCS Business Messaging (RBM) functionality for their enterprise clients.
  • Basic RCS leverages Interop Technologies’ leading RBM platform to facilitate branded, authenticated, and encrypted bidirectional RCS communications without the need to upgrade existing SMS messaging ingress methods.
  • If the end-user device is RCS capable, then the message is wrapped in an RCS envelope that includes pre-determined associated branding and it is delivered as an RCS message.

NextEvo Naturals Releases Early Results of Prospective Study on Novel Water-Soluble CBD Oral Formulation

Retrieved on: 
Tuesday, July 11, 2023
Cannabinoid, Pharmacokinetics, PD, Safety, Research, Biomarker, RBM, Vaccine, CBD

CONSHOHOCKEN, PA, July 11, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire - NextEvo Naturals (“NextEvo” or the “Company”), a premium supplement brand focused on revolutionizing the delivery of nutritional compounds, announced today early results from the successful completion of a prospective study on its groundbreaking water-soluble cannabidiol (CBD) oral formulation.

Key Points: 
  • CONSHOHOCKEN, PA, July 11, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire - NextEvo Naturals (“NextEvo” or the “Company”), a premium supplement brand focused on revolutionizing the delivery of nutritional compounds, announced today early results from the successful completion of a prospective study on its groundbreaking water-soluble cannabidiol (CBD) oral formulation.
  • Over a three-day period, NextEvo Naturals' novel CBD formulation was tested at two concentrations consumed at twice daily intervals.
  • One of the most compelling findings of the study was the significant modulation LPS-stimulated whole blood cytokines assays(TruCulture, RBM), highlighting the potential immunomodulatory effects of NextEvo Naturals' CBD formulation.
  • "This study represents a crucial step forward in our understanding of CBD's potential impact on the immune response,” said John McDonagh, CEO of NextEvo Naturals.

Rio Tinto releases fourth quarter production results

Retrieved on: 
Monday, January 16, 2023
Mining, Minerals, Natural Resources, Gove, Cortez, Development, SPS, Royal Gold, Iron Ore Company of Canada, Culture, Native title in Australia, Safety, Copper, Health, Tax, Maintenance, Australian Taxation Office, Research and development, Water, Rio Tinto, Oyu Tolgoi mine, Workforce, Sale, Rough Riders, Kennicott, Acquisition, Richards Bay Minerals, IOC, Smurfit Kappa, Electricity, RBM, Iron ore, Renewable energy, Kitimat, Neste, Research, Weipa

The rate of pot restarts at Kitimat picked up in the fourth quarter and Boyne smelter cell recovery efforts continued.

Key Points: 
  • The rate of pot restarts at Kitimat picked up in the fourth quarter and Boyne smelter cell recovery efforts continued.
  • Unplanned maintenance was required at Kennecott in the fourth quarter of 2022 in our anode furnaces leading to extended downtime and continued poor anode production, likely to result in weak cathode production in the first quarter of 2023.
  • Production constraints related to nationwide electrical power loadshedding at RBM were experienced in the fourth quarter.
  • Successful deployment of the Rio Tinto Safe Production System (SPS) at the concentrator was completed in the year, with record performance metrics achieved in the year, including monthly records for concentrate production and total material moved in the second quarter.

eClinical Solutions’ Thought Leaders to Discuss the Future of Data Standards, Risk-Based Approaches, and Digital Trials at PHUSE EU Connect 2022, Medidata NEXT New York 2022 and More

Retrieved on: 
Thursday, November 10, 2022
Data Management, Health, Technology, Other Science, Software, General Health, Science, Cloud, RBM, Clinical data management, Cubana de Aviación Flight 455, Metadata, Quality, Impact of the COVID-19 pandemic on science and technology, SCE, Organization, Digital, Technology, Framework, Efficiency, Decentralization, Solution, Compliance, Statistics, Cros, Importance, Cons, Pros, Patient, CEO, Industry, Acquisition, CDISC, NEXT, Map, CNS, FDA, Pharmaceutical industry, Medical imaging

As we look to the future of clinical trials, data complexity will only continue to grow simultaneously with expectations to accelerate study timelines.

Key Points: 
  • As we look to the future of clinical trials, data complexity will only continue to grow simultaneously with expectations to accelerate study timelines.
  • Achilleas will explain how the elluminate Clinical Data Cloud enables users to ingest, integrate, map, and standardize data from any source.
  • eClinical Solutions European team will be at booth # 3 showing how elluminate provides one source of truth for clinical and operational data.
  • eClinical Solutions helps life sciences organizations around the world accelerate their digital clinical initiatives with modern data infrastructure and analytics.

Rio Tinto partners with Voltalia for renewable solar power at Richards Bay Minerals

Retrieved on: 
Thursday, October 6, 2022
Natural Resources, Alternative Energy, Energy, Mining, Minerals, Utilities, Electricity, Woman, Richards Bay Minerals, Carbon, Workforce, BEE, African, Solution, RBM, Renewable energy

Richards Bay Minerals (RBM) will be supplied with renewable solar power through an agreement with international energy company Voltalia and local Black Economic Empowerment (BEE) partners, for its operation in KwaZulu-Natal, South Africa.

Key Points: 
  • Richards Bay Minerals (RBM) will be supplied with renewable solar power through an agreement with international energy company Voltalia and local Black Economic Empowerment (BEE) partners, for its operation in KwaZulu-Natal, South Africa.
  • Under the agreement, Voltalia will begin construction of the Bolobedu Solar PV renewable energy project in 2023, at a site in the province of Limpopo.
  • The power plant is scheduled to be complete by 2024 and will deliver an annual generation capacity of up to 300GWh.
  • As this solar energy project progresses, we will continue exploring additional renewable solutions that further reduce our emissions in South Africa and make Richards Bay Minerals a contributor to our net zero commitment.

eClinical Solutions Thought Leaders to Discuss Managing Evolution of Clinical Data, Standards, and Technology at SCDM, DPHARM, CDISC, Among Other Upcoming Industry Conferences

Retrieved on: 
Thursday, September 8, 2022
Science, Software, Research, Health, Artificial Intelligence, Data Management, Technology, Clinical Trials, Cloud, Machine learning, DCTS, Patient, CEO, Technology, Natural history study, Clinical data management, CDISC, Research, Digital, Solution, Efficiency, Biogen, CDR, RBM, OCT, CT, Real, Data management, Organization, Adoption, Classification, Intention, Conference, Compliance, ROI, RWD, Challenge, Summit, Clinical trial, DCT, Automation, Industry, Society, Metadata, AI, Medical device, Pharmaceutical industry, Medical imaging, Registry

eClinical Solutions will also be presenting and exhibiting at DPHARM 2022 (September 13-14) in Boston, MA.

Key Points: 
  • eClinical Solutions will also be presenting and exhibiting at DPHARM 2022 (September 13-14) in Boston, MA.
  • The eClinical Solutions team will also be available in booth #48a of the exhibit hall to demonstrate elluminate.
  • eClinical Solutions will close out the month of October at the 2022 Clinical Data Interchange Standards Consortium (CDISC) US Interchange (October 26-27) in Austin, TX.
  • eClinical Solutions helps life sciences organizations around the world accelerate their digital clinical initiatives with modern data infrastructure and analytics.

eClinical Solutions Included in Gartner® ‘Hype Cycle™ for Life Science Clinical Development, 2022’

Retrieved on: 
Thursday, August 18, 2022
Data Management, Biotechnology, Technology, Professional Services, Health, Pharmaceutical, Health Technology, Medical Devices, Data Analytics, Software, Clinical Trials, Cloud, Laboratory, Clinical data management, CEO, Technology, CIOS, Clinical trial, Hype cycle, Research, Data science, Digital data, Biotechnology, Safety, Publication, Central Monitoring System, Organization, Solution, RBM, Cros, SDV, Adoption, Medical device, Fine chemical, Pharmaceutical industry, Software, Medical imaging, Gartner

eClinical Solutions , a global provider of digital clinical software and services, today announced it has been named as a 2022 Gartner Hype Cycle for Life Science Clinical Development Sample Vendor in three categories including Clinical Data Analytics Platforms, Risk-Based and Centralized Monitoring, and Clinical Trial Resource Management.

Key Points: 
  • eClinical Solutions , a global provider of digital clinical software and services, today announced it has been named as a 2022 Gartner Hype Cycle for Life Science Clinical Development Sample Vendor in three categories including Clinical Data Analytics Platforms, Risk-Based and Centralized Monitoring, and Clinical Trial Resource Management.
  • According to Gartner, clinical data analytics platforms bring modern data and analytics approaches to clinical trial data processes, expanding on existing clinical data repository solutions and data science laboratories by integrating them under a modern logical data warehouse architecture.
  • eClinical Solutions is extremely proud of our Gartner recognition across all three categories in which we were included in this Hype Cycle report, said Raj Indupuri, CEO, eClinical Solutions.
  • For more information about eClinical Solutions inclusion in the 2022 Gartner Hype Cycle and to download a full copy of the report, please click here .